Medicine
Methohexital 500 mg/500 mg injection
Methohexital 500 mg/500 mg injection is a generic prescription medicine for intravenous use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Methohexital Sodium for Injection is a white, freeze-dried plug/lyophilized…
Key facts
- Active ingredient (INN)
- Methohexital
- Brand
- Sold under the generic name
- Strength
- 500 mg/500 mg
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 500 mg
- Manufacturer
- Onesource Specialty Pharma
- Origin register
- US FDA, United States
- Storage
- Methohexital Sodium for Injection is a white, freeze-dried plug/lyophilized cake, filled in Vials*: The 500 mg vials (with 30 mg anhydrous sodium carbonate) are available as follows: • NDC 83270-003-01– Multi-Dose Vial – Pack of 1 *In crystalline form. Store between 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Schedule CIV
- ATC code
- N01AF01 Methohexital
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 24 January 2026
- Identifiers
- RxCUI 1244233DailyMed set ID 6fb09acf-4937-47a0-a9da-084ec062da6fNDC 83270-003Application ANDA215488
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 500 mg in 1 vial | 83270-003-01 | Onesource Specialty Pharma | 24 January 2026 |
| 1 vial in 1 carton / 500 mg in 1 vial | 23155-893-31 | — | 12 December 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 27 June 1960 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Methohexital 500 mg/500 mg injection.
Other strengths and forms of Methohexital
Clinical summary
Methohexital is a barbiturate. It is available as injection and powder for injection for intravenous, intramuscular and rectal use. MedsAcross supplies Methohexital for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MethohexitalFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Brevital Sodium prescribing information (Par Health) · U.S. National Library of Medicine, DailyMed
Need Methohexital 500 mg/500 mg injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.